MedPath

An Exploratory Randomized Controlled Study of Arthroscopic Inlay Bristow Procedure for Recurrent Anterior Shoulder Dislocation

Not Applicable
Completed
Conditions
Shoulder Dislocation
Interventions
Procedure: Bristow
Procedure: Inlay Bristow
Registration Number
NCT04949217
Lead Sponsor
Peking University Third Hospital
Brief Summary

To evaluate the clinical and radiographic outcomes of arthroscopic inlay bristow procedure in treating recurrent anterior shoulder instability.

Detailed Description

Aim: To compare the clinical and radiographic outcomes following the arthroscopic Chinese Unique Inlay Bristow (Cuistow) procedure and the arthroscopic Bristow procedure.

Background: The Cuistow procedure is a modified Bristow surgery in which a Mortise and Tenon structure was added to the contact surface between the coracoid tip and the glenoid. In previous retrospective study, patients received Cuistow procedure have satisfying clinical performance and excellent postoperative bone healing rate (96.1%). However, no prospective randomized controlled trial was performed.

Methods: 70 patients with recurrent anterior shoulder instability were included and randomized to either an arthroscopic Cuistow procedure or arthroscopic Bristow procedure. Radiological evaluations with 3D CT scan were performed preoperatively, immediately after the operation, and postoperatively at three months and during the final follow-up (more than 2 years). Clinical assessment for a minimum of 24 months including the 10-point visual analog scale for pain and subjective instability, University of California at Los Angeles scoring system (UCLA score), American Shoulder and Elbow Surgeons score (ASES score), ROWE score, Subjective Shoulder Value (SSV) and active range of motion were completed by independent observers and analyzed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Recurrent anterior shoulder instability based on medical history, physical examination, and radiological results.
  • A glenoid defect ≥10% but <25%
  • Participation in high-demand (collision and overhead) sports combined with the presence of a glenoid defect <25% of the glenoid or without defect
  • Failure after Bankart repair
Read More
Exclusion Criteria
  • Multi-directional shoulder instability
  • Uncontrolled epilepsy
  • History of receiving Bristow-Latarjet procedure.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Onlay Bristow GroupBristowOnlay Bristow procedure
Inlay Bristow GroupInlay BristowInlay Bristow procedure
Primary Outcome Measures
NameTimeMethod
ASES score2-year postoperatively

The ASES score (Michener 2002) is a 10-item measure of shoulder pain and function. Pain is assessed on a 10-cm visual analog scale (VAS) and accounts for 50% of the total score. The remaining 50% of the score is determined by the responses to 10 4-point Likert-scale questions related to physical function.

Bone union rate2-year postoperatively

Bone healing was observed in 3DCT. The bone healing rate was obtained by dividing the number of people who achieved bone healing by the total number of people

Secondary Outcome Measures
NameTimeMethod
VAS for pain score2-year postoperatively

The visual analog scale (VAS) for pain score is the most commonly used to describe pain levels in patients, ranging from 0 to 10, with a higher score indicating more intense pain.

Active shoulder ranges of motion2-year postoperatively

internal rotation at the side, and external and internal rotation at 90° of abduction

dislocation rate2-year postoperatively

The dislocation rate was obtained by dividing the number of people who dislocated postopratively by the total number of people

© Copyright 2025. All Rights Reserved by MedPath